Swiss biotech startup Hedera Dx raises €14m seed funding to accelerate global adoption of liquid biopsies
Hedera Dx, a Swiss biotech startup, has raised €14 million in funding to launch a blood-based testing solution to profile cancer DNA circulating in the blood, helping patients access better treatments.
Tridek-One, a Paris-based biotech startup specialized in the research and development of CD31 agonists to restore the immune balance, announced it has closed a €16 million financing round led by the Swiss VC Pureos Bioventures.
Finnish biotech startup Onego Bio secures €4.5m additional funding to accelerate Research & Development
Business Finland, a public organization under the Finnish Ministry of Employment and the Economy, has awarded a grant of additional €4.5 million for Onego Bio's research and development work.
Chinese biotech startup CellOrigin partners with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy
CellOrigin Biotech has made an agreement with Qilu Pharmaceutical on strategic global collaborations to develop, manufacture and commercialize a proprietary "off-the-shelf" CAR-iMAC cell therapy.
Paris, France-based Eurobio Scientific (Eurobio) has reached agreement to acquire all outstanding shares of Dutch-based transplant diagnostics startup GenDx for an amount of €135 million (net of adjusted cash) to be paid in cash at closing to its current shareholders.
BASF Venture Capital and Dutch-based Aqua-Spark invest in Sea6 Energy as part of Series B financing round
BASF Venture Capital, the corporate venture company of BASF SE, Germany, and Aqua-Spark, a Dutch investment fund focusing on the global aquaculture industry, are investing in Sea6 Energy as part of a Series B round.
West Pharmaceutical Services, a global player in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch Medical, a Dublin-based startup leading in next-generation vaccine and biologics delivery technology.
Taiwan startup PrecisemAb announces progress towards vision of safest antibody treatment with no side effects
PrecisemAb Biotech, a biotechnology research company based in Kaohsiung, Taiwan, announced it has continued to stay true to its vision of enhancing antibody drugs by reducing side effects.
Novasenta, a biotechnology startup focused on the discovery and validation of novel targets to develop cancer therapies, today announced the completion of $40 million in Series A financing led by UPMC Enterprises.
Canadian biotech startup Spiderwort secures $13.2m financing to accelerate clinical trials of biomaterials
Spiderwort, the biotech company innovating in cellulose-based tissue scaffolding to treat acute spinal cord injuries, announced the successful completion of its $13.2 million Series A financing.
Phytolon, the developer of fermentation-based natural food colors, announced it has secured $14.5 million Series A funding, led by DSM Venturing, to further progress its technology towards commercialization.
London-based AI startup Peptone closes $40m Series A funding to build a state-of-the-art research facility in Bellinzona
Peptone, the molecular computational physics company focused on protein drug discovery, announced the successful completion of a $40 million Series A financing round.
CimCure, a biotech spin-off of Amsterdam UMC, focusing on the development of a novel vaccine-based cancer immunotherapy through its Immune-Boost (iBoost) technology, announced it has raised little over € 5 million in a financing Seed Round.
META Pharmaceuticals, China's first immunometabolism-based small-molecule drug discovery company, announced two consecutive Seed and Pre-A funding rounds totaling $15 million.
Biotech startup Transine Therapeutics closes £13.7m seed round to accelerate its platform and portfolio development
Transine Therapeutics (Transine), a biotechnology company, announced it has successfully raised £4.6 million in additional seed funding.
Evolved Meats ("Evolved"; formerly known as CaroMeats), a Canadian biotechnology startup, has raised $2 million in its seed round to accelerate its product development and to support the initial scale up of its production processes.
Kruze Consulting, a CPA and finance consulting company for VC-backed startups, released new data on the average salary for startup CEOs.
AskGene, a clinical-stage biopharmaceutical company focusing on discovery and development of innovative biological drugs, announced the completion of $20 million in Series A financing.
Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, announced the final closings for the Breakthrough Life Science Property Fund.
SeaX Ventures (Southeast Asia Exponential Ventures), announced the close of its second fund to help accelerate the growth of global startups throughout Southeast Asia.
Cambridge-based startup Sano Genetics announced it has raised $11 million in a Series A funding round led by MMC Ventures, with further funding from Episode 1, Seedcamp and several experienced operators in software and life sciences.
TandemAI has announced it has raised $25 million in Seed and pre-Series A financing to advance its proprietary computational platform and expansion of its wet lab operations.
Biotechnology startup Tiamat Sciences announced its $3 million seed financing round led by Silicon Valley venture capital firm True Ventures with participation from Social Impact Capital and Cantos.
Illumina and Sequoia Capital China, an investment firm, jointly announced the selection of the first two startup companies joining the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.
Shiru, a biotech startup that identifies and creates novel plant-based ingredients for the global food industry, closed a $17 million Series A round led by S2G Ventures and joined by returning investors Lux Capital, CPT Capital, Y Combinator, and Emles Venture Partners.
Dalan Animal Health startup raises $1.9m seed funding for development of a breakthrough honeybee vaccine
Dalan Animal Health, Inc., a biotech company developing vaccines for new age production animals, announced it has closed funding for a $1.9 million seed round.
Biotech startup Elevian raises $40m Series A to advance treatments for stroke recovery and age-related diseases
Elevian, an emerging biotech company developing medicines that restore youthful regenerative capacity with the potential to treat and prevent multiple age-related diseases, announced it raised $40 million in an oversubscribed Series A round led by Prime Movers Lab.
Illumina has selected seven new genomics companies to join the third global funding cycle of Illumina Accelerator. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups.
South Africa and US-based biotech startup LifeQ secured $47 million in Series A funding from One Bio Venture Studio, a Cape Town-based VC and several other investors.
Eliem Therapeutics, a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in disorders of the peripheral and central nervous systems, announced the closing of a $60 million Series B financing.
Alebund Pharmaceuticals, a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced the raise of $60 million in its Series B financing round.
Gilgamesh Pharmaceuticals, a mental health science focused biotechnology company utilizing psychedelic-related medicines for the treatment of neuropsychiatric conditions, today announced the closing of a $27 million Series A round of funding.
University of Alabama at Birmingham's biotech startup ResBiotic, announced a $3 million seed round to support the development and commercialization of groundbreaking probiotic formulations for lung health.
Danish biotech startup Adcendo raises €51m to advance novel antibody-drug conjugates for cancers treatment
Adcendo, a biotech company developing antibody-drug conjugates (ADCs) for the treatment of cancers, announced the successful closing of €51 million Series A financing to advance novel antibody-drug conjugates for treatment of cancers.
Finnish biotech startup Carbo Culture sets to remove 1billion tons of carbon from atmosphere by 2030
Carbo Culture, a biotech startup commercialising large-scale carbon removal, has a north star vision to remove 1 billion tons (1Gt) of carbon from the atmosphere by 2030.
Chinese biotech startup Bioheng raises $80m in Series B financing to advance allogeneic immuno-cell therapies
Bioheng Biotech, a clinical-stage biotechnology company dedicated on developing novel cellular immunotherapy for cancer, announced that it had secured $80 million in Series B Financing.
Nano Cures (Nano), a clinical stage biotechnology and infectious disease immunity platform company, announced a $90 million pre-IPO funding round.
Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways, announced the completion of a $30 million Series A financing.
GoStork, the first fertility marketplace, announced its first round of seed funding in the amount of $760,000 for the expansion of services, providers and key staff to simplify the first steps in the family building journey.
Micronoma, the first cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, announced the closing of $3.5 million in convertible debt financing.
Adjuvant Capital announced an oversubscribed $300 million fund focused on accelerating the development of medical innovations for historically overlooked public health challenges.
Forward BIOLABS, a co-working life science lab that helps bioscience startups grow, is celebrating early successes and honoring the companies that support the organization.
Prime Movers Lab, an investor in breakthrough scientific startups that will revolutionize the world's most important industries and transform billions of lives, announced that it is expanding its efforts in the life sciences.
MindMed partners with Swiss psychedelic drug discovery startup MindShift Compounds to patent next-gen psychedelic compounds
MindMed, a psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties.
Proxima Ventures, Co-win Ventures invest in Bioelectronica to accelerate pharmaceutical discovery and development
Bioelectronica announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company's innovations in digital biochemistry, from novel assay development to scalable electrofluidics.
Mammogen, Inc., a women's health startup born at the intersection of data, technology and science, and Bench International, a leading global executive search firm, jointly announce the appointment of Elizabeth Cormier-May as Chief Executive Officer.
Biotech startup Vera Therapeutics launches with $80m Series C financing to develop phase 2b novel biologic for kidney disease
Vera Therapeutics, a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases, announced its launch backed by $80 million Series C financing led by Abingworth LLP.
AltPep Corporation, a privately held biomedical company focused on diagnosing and treating Central Nervous System amyloid disorders, starting with Alzheimer's Disease, announced it closed a $23.150 million Series A investment round.
Novo Seeds' IO Biotech completes oversubscribed €127m Series B financing to accelerate clinical programs in oncology
Novo Seeds announced its portfolio company, IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies, raised €127 million in Series B financing.
Theolytics, a UK biotech harnessing viruses to combat cancer, announced the closing of £5 million Series A round, co-led by Epidarex Capital and Taiho Ventures LLC with participation from existing investor, Oxford Sciences Innovation (OSI).
CerraCap Ventures announced its third health-tech investment in Totient, an artificial intelligence-driven drug discovery platform that identifies and harnesses human-derived antibodies from individuals with exceptional immune responses.
Indee Labs announced the addition of three of the largest pharmaceutical companies, multiple biotechnology companies as well as Stanford's Cell Therapy Clinic and Moffitt Cancer Center, to participate in its Early Access Program.
TurtleTree Labs, a biotech company pioneering the method to produce milk using cell-based technology, announced the close of an oversubscribed $6.2 million Pre-A funding round from new and existing global investors.
Biometrics startup Levels raises $12m seed round to mainstream Biowearables, improve metabolic health
Levels, the first biowearable system to provide real-time feedback on how your diet impacts your health announced a $12 million seed round led by a16z, one of Silicon Valley's top venture capital firms.
Mekonos, a biotech company launching the first-of-its kind system-on-a-chip (SoC) for targeted ex vivo gene engineering, announced it has completed a $4.6 million financing round.
Swiss biotech startup Memo Therapeutics raises €13.9m to support clinical development of potent antibodies
Swiss biotech startup Memo Therapeutics AG, an innovator in the field of antibody discovery and immune repertoire analysis, announced it has raised €13.9 million in Series B financing.
Seattle biotech startup Genemod raises $1.7m in oversubscribed seed round to drive next generation medicine
Genemod, a software solution for life scientists that uses data automation to streamline and accelerate research announced a $1.7 million seed funding round led by Defy.vc.
Cognoptix, a US healthcare company developing the Sapphire II System, a breakthrough technology for early detection of Alzheimer's disease (AD), has announced the closing of an over-subscribed Series R financing round.
Siolta Therapeutics, a clinical-stage biotech company in the US, has raised $30 million in a series B investment round to support the clinical development of its lead product.
Israel-based Phytolon, a portfolio company of The Trendlines Group Ltd has announced that it secured $4.1 million in funding for its fermentation-based technology for the production of plant-based food colours.
Inflazome has announced that it has closed a share purchase agreement with Roche in which Inflazome’s shareholders received an upfront payment of €380 million.